PAK1 and hepatocellular carcinoma: Consistent with a role for PAK1 in regulating inducible macropinocytosis [20], we observed a marked increase in phosphorylated PAK1 in sorafenib-treated human HCC tissues (Fig. 1A, B and Fig. S1B).